# Safety Study of CD-NP in Heart Failure

> **NCT00557661** · PHASE1 · COMPLETED · sponsor: **Nile Therapeutics** · enrollment: 20 (actual)

## Conditions studied

- Congestive Heart Failure

## Interventions

- **DRUG:** CD-NP

## Key facts

- **NCT ID:** NCT00557661
- **Lead sponsor:** Nile Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** —
- **Final completion:** 2008-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2009-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00557661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00557661, "Safety Study of CD-NP in Heart Failure". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00557661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*